<DOC>
<DOCNO>EP-0646578</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them
</INVENTION-TITLE>
<CLASSIFICATIONS>A61P3500	A61P2900	A61K3142	C07D26100	A61P1902	A61P3500	A61K3142	A61P1900	A61P2900	C07D26118	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61P	A61P	A61K	C07D	A61P	A61P	A61K	A61P	A61P	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61P35	A61P29	A61K31	C07D261	A61P19	A61P35	A61K31	A61P19	A61P29	C07D261	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The compounds of formula (I): 
<
IMAGE
>
  [in which   R1 represents a hydrogen atom or an alkyl group containing 1 to 3 carbon atoms;   R2 represents a cycloalkyl group containing 3 to 6 carbon atoms; R4 represents a halogen atom, a nitrile group, a nitro group, an -SCH3 group, a C1-6 alkylcarbonyl group, a C3-6 cycloalkylcarbonyl group, a -CX3 group, a -WCX3 group, a -(CH2)nCX3 group, a -(CX2)n CX3 group, a -W(CX2)nCX3 group or a -W(CH2)nCX3 group, in which X represents a halogen atom, W represents an oxygen or sulphur atom and n represents 1, 2 or 3; and R5 represents a hydrogen atom, an alkyl group containing 1 to 3 carbon atoms or a cycloalkyl group containing 3 to 6 carbon atoms; provided that, if R5 represents a hydrogen atom, R4 does not represent an -SCH3 or -CF3 group]; and their salts have an anti-proliferative, anti-inflammatory and anti-tumour activity. A description is also given of processes for their preparation, of the compositions which contain them and of their use in therapeutics.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
HOECHST MARION ROUSSEL INC
</APPLICANT-NAME>
<APPLICANT-NAME>
HOECHST MARION ROUSSEL
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
KUO ELIZABETH ANNE
</INVENTOR-NAME>
<INVENTOR-NAME>
WESTWOOD ROBERT
</INVENTOR-NAME>
<INVENTOR-NAME>
KUO, ELIZABETH ANNE
</INVENTOR-NAME>
<INVENTOR-NAME>
WESTWOOD, ROBERT
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Compounds of formula (I):


[in which

R
1
 represents a hydrogen atom or an alkyl group containing 1
to 3 carbon atoms;
R
2
 represents a cycloalkyl group containing 3 to 6 carbon
atoms;
R
4
 represents a halogen atom, a nitrile group, a nitro group,
an -SCH
3
 group, a C
1-6
 alkylcarbonyl group, a C
3-6

cycloalkylcarbonyl group, a -CX
3
 group, a -WCX
3
 group, a
-(CH
2
)
n
CX
3
 group, a -(CX
2
)
n
CX
3
 group, a -W(CX
2
)
n
CX
3
 group or a
-W(CH
2
)
n
CX
3
 group,
in which X represents a halogen atom, W represents an oxygen
or sulphur atom, and n represents 1, 2 or 3; and
R
5
 represents a methyl group;

and their salts.
Compounds according to claim 1, in which

R
1
 represents a hydrogen atom;
R
2
 represents a cyclopropyl group;
R
4
 represents a halogen atom, a nitrile group, a nitro group,
a -CF
3
 group, a -C
2
F
5
 group, an -OCF
3
 group or an -SCF
3
 group;
and R
5
 represents a methyl group.
Compounds according to claim 1 or claim 2, in which

R
4
 represents a halogen atom or a nitrile group, a nitro group
or a -CF
3
 group; and
R
5
 represents a methyl group.
Compounds according to any one of claims 1 to 3, in
which


R
4
 represents a bromine or chlorine atom or a nitrile or -CF
3

group; and
R
5
 represents a methyl group.
Compounds according to any one of claims 1 to 5,
selected from:


5-cyclopropyl-N-(4-bromo-3-methylphenyl)-isoxazole-4-carboxamide;
5-cyclopropyl-N-(4-chloro-3-methylphenyl)-isoxazole-4-carboxamide;
5-cyclopropyl-N-(4-cyano-3-methylphenyl)-isoxazole-4-carboxamide;
5-cyclopropyl-N-(4-trifluoromethyl-3-methylphenyl)-isoxazole-4-carboxamide;

and their salts.
Process for the preparation of a compound of formula
(I) according to any one of claims 1 to 5, comprising the

reaction of a compound of formula (II)

 
(in which R
1
, R
4
 and R
5
 are as defined in claim 1) with a
compound of formula (III)



(in which R
2
 is as defined in claim 1) or a suitable
functional derivative of the latter.
Medicament constituted by novel compounds of formula
(I) according to any one of claims 1 to 5 as well as their

pharmaceutically acceptable salts.
Medicament constituted by novel compounds of formula
(I) according to any one of claims 1 to 4, in which R
5

represents a methyl group, as well as their pharmaceutically
acceptable salts.
Pharmaceutical compositions containing as active
ingredient at least one compound of formula (I) according to

any one of claims 1 to 5 or a pharmaceutically acceptable
salt in combination with one or more supports and/or

pharmaceutical excipients.
</CLAIMS>
</TEXT>
</DOC>
